Evidence map›Paper›PMID 39329148›Full record

ArticleMolecular therapy. Nucleic acids2024

Identification of a histone deacetylase inhibitor as a therapeutic candidate for congenital central hypoventilation syndrome.

Chiara Africano, Tiziana Bachetti, Paolo Uva, Gabriel Pitollat, Genny Del Zotto, Francesca Giacopelli, Giada Recchi, Nicolas Lenfant, Amélia Madani, Nathan Beckouche and 2 more

Abstract read
In one paragraph

Article in Molecular therapy. Nucleic acids, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. TheFrontiers in physiology · 2025
    Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Chiara AfricanoLaboratory of Genetics and Genomics of Rare Diseases, IRCCS Istituto Giannina Gaslini, 16147 Genova, Italy.
Tiziana BachettiOU Proteomics and Mass Spectrometry, IRCCS Ospedale Policlinico San Martino, 16132 Genova, Italy.
Paolo UvaClinical Bioinformatics Unit, IRCCS Istituto Giannina Gaslini, 16147 Genova, Italy.
Gabriel PitollatUniversity of Bordeaux, CNRS, INCIA, UMR 5287, 33000 Bordeaux, France.
Genny Del ZottoCore Facilities, Department of Research and Diagnostics, IRCCS Istituto Giannina Gaslini, 16147 Genova, Italy.
Francesca GiacopelliCentral Laboratory of Analysis, IRCCS Istituto Giannina Gaslini, 16147 Genova, Italy.
Giada RecchiLaboratory of Genetics and Genomics of Rare Diseases, IRCCS Istituto Giannina Gaslini, 16147 Genova, Italy.
Nicolas LenfantAix Marseille University, INSERM, MMG, U1251, Marseille, France.
Amélia MadaniUniversité Paris Cité, INSERM, NeuroDiderot, 75019 Paris, France.
Nathan BeckoucheAtmosR, 13710 Fuveau, France.
Muriel Thoby-BrissonUniversity of Bordeaux, CNRS, INCIA, UMR 5287, 33000 Bordeaux, France.
Isabella CeccheriniLaboratory of Genetics and Genomics of Rare Diseases, IRCCS Istituto Giannina Gaslini, 16147 Genova, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Congenital central hypoventilation syndrome (CCHS), a rare genetic disease caused by heterozygous

Indexed as

aggregatesbreathingCCHSMT: Bioinformaticspharmacological treatmentPHOX2B

Identifiers

PMID39329148
PMCPMC11426119

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.